Course

Caffeine and Anxiety Disorders

Course Highlights


  • In this Caffeine and Anxiety Disorders course, we will learn about the epidemiological context of anxiety disorders.
  • You’ll also learn the mechanisms of caffeine’s effects on neurophysiology.
  • You’ll leave this course with a broader understanding of the impact of caffeine on anxiety disorders.

About

Contact Hours Awarded:

Course By:
R. E. Hengsterman

MSN, RN

Begin Now

Read Course  |  Complete Survey  |  Claim Credit

Read and Learn

The following course content

Introduction 

It is important to explore the impact of caffeine intake for those with anxiety disorders. Healthcare providers should be knowledgeable on etiology, pathophysiology, and signs and symptoms of anxiety disorders. Nurses have an impactful platform to recognize any negative impact that caffeine has on patients and provide appropriate patient education. 

 

Overview on Anxiety Disorders 

Anxiety disorders are a collective term for a variety of conditions characterized by excessive worry, fear, and apprehension including generalized anxiety disorder, panic disorder, social anxiety disorder, and various phobia-related disorders (1). Given the widespread impact of anxiety disorders, understanding the effects of caffeine consumption on individuals with anxiety is crucial for effective diagnosis and treatment.

Quiz Questions

Self Quiz

Ask yourself...

  1. How might the widespread consumption of caffeine in society affect our understanding and treatment of anxiety disorders? 

Statistical Evidence and Epidemiology of Anxiety Disorders 

Anxiety disorders are among the most prevalent mental health conditions in the United States, affecting 40 million adults, or approximately 18.1% of the population annually (2). According to the World Health Organization (WHO), around 300 million people worldwide suffer from anxiety disorders (3). These statistics make it evident that anxiety is not confined to any one geographical location, age group, or demographic but is a pervasive issue across the globe. The lifetime prevalence is even higher, affecting almost one-third of the adult population at some point in their lifetimes (4).  

Understanding the epidemiology and statistical evidence related to anxiety disorders can offer valuable insights into the scale and scope of this public health issue. 

Quiz Questions

Self Quiz

Ask yourself...

  1. Considering that anxiety disorders affect almost 20% of the U.S. adult population per year, how should the healthcare system prioritize its resources to better understand and treat this prevalent mental health condition? 
  2. Can you discuss the universal aspects versus culturally specific factors of anxiety disorders? 

Gender Disparities 

Anxiety disorders are more common in females than males (5). Research indicates that women are two times more likely to suffer from anxiety disorders compared to men. The underlying biological factors and mechanisms are not known, but genetic factors, environmental factors, hormonal fluctuations, and sociocultural factors may contribute to this gender disparity (6). In addition, anxiety disorders are associated with a greater illness burden in European American and Hispanic women (5).  

It is important to note that although women may report anxiety disorders at a greater frequency, this doesn’t mean that men are unaffected; males may underreport symptoms due to societal stigmas related to mental health (7).

Quiz Questions

Self Quiz

Ask yourself...

  1. How might demographic data guide healthcare strategies for early intervention and treatment?  
  2. How should healthcare policies address the potential underreporting of symptoms in men due to societal stigmas? 

Age of Onset 

Anxiety disorders can develop at any age, but the risk appears to be highest in childhood and early adulthood (8). The National Comorbidity Survey Replication reports that the median age of onset for anxiety disorders is 11 years old (3). Early onset can have long-term implications such as negative academic impact, career progression, and overall quality of life (10).

Quiz Questions

Self Quiz

Ask yourself...

  1. Given that the median age of onset for anxiety disorders is 11 years old and that early onset can have a profound impact on educational attainment, career progression, and overall quality of life, what should be the focus of preventative healthcare strategies?  

Types of Anxiety Disorders 

The prevalence of specific types of anxiety disorders can vary. Generalized Anxiety Disorder (GAD) has a 12-month prevalence of about 5% among U.S. adults, while Social Anxiety Disorder has a slightly higher rate of around 7% along with post-traumatic stress disorder (PTSD). Panic Disorder affects about 7% of the adult population, Specific Phobias can be as high as 9% and 1.6% for obsessive-compulsive disorder (OCD) (15).

Quiz Questions

Self Quiz

Ask yourself...

  1. Given the varying prevalence rates of specific types of anxiety disorders, such as Generalized Anxiety Disorder (GAD) at 5% and Specific Phobias at 9%, how might healthcare systems need to prioritize their resources and treatments to manage this range of conditions?  
Comorbidities 

Anxiety disorders often co-occur with other mental health conditions, such as depression or substance abuse disorders (12). The National Institute of Mental Health (NIMH) states that nearly half of those diagnosed with depression are also diagnosed with an anxiety disorder (13).  

Socioeconomic Factors 

Lower socioeconomic status has been linked to a higher prevalence of panic attacks, all types of phobias, and generalized anxiety disorder (14). Lack of access to quality healthcare, increased exposure to stressors, and limited educational opportunities also contribute to anxiety (15). 

 

Etiology 

The origins of anxiety disorders are multifactorial, involving a complex interplay between genetic predispositions, environmental factors, and individual psychological aspects [6].  

Having a family history of anxiety or other mental health conditions can increase one’s risk. Environmental stressors such as trauma, abuse, or significant life changes are also key contributors (13). Personality traits, like neuroticism or perfectionism, can further predispose an individual to develop an anxiety disorder (14). Twin and family studies have demonstrated that genetic factors can contribute to an individual’s susceptibility to anxiety disorders. The heritability estimates range from 30-40%, suggesting a significant genetic component (16).

Quiz Questions

Self Quiz

Ask yourself...

  1. Can you discuss the link between anxiety disorders and factors such as genetic predispositions, environmental factors, and individual psychological traits?  

Pathophysiology 

The pathophysiology of anxiety disorders is believed to involve neuroendocrine, neurotransmitter, and neuroanatomical disruptions in the brain involving serotonin, dopamine, and norepinephrine (17).  

The amygdala, a region of the brain comprised of at least 13 different subnuclei, one of which (CeA) controls many aspects of the fear response, including regulation of the release of cortisol (18). When activated, it can trigger the ‘fight or flight’ response, leading to symptoms such as rapid heartbeat and shortness of breath, which are commonly associated with anxiety states (18). 

Quiz Questions

Self Quiz

Ask yourself...

  1. How can knowledge on the pathophysiology of anxiety disorders contribute to the development and evaluation of pharmacological and non-pharmacological treatments?  

Signs and Symptoms of Anxiety Disorders 

The clinical presentation of anxiety disorders can vary, but it often includes excessive feelings of doom, diaphoresis, fear, trembling, tachycardia, chest pain and irritability (1). These symptoms can impair daily functioning and quality of life. 

 

Clinical Criteria for Diagnosis  

Diagnosis of anxiety disorders relies on criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (10).  

For example, GAD is often diagnosed if excessive worry (apprehensive expectation), occurring more days than not for at least 6 months with three or more of the following six symptoms: (1) Restlessness or feeling on edge, (2) fatigue, (3) difficulty concentrating, (4) irritability, (5) muscle tension and (6) sleep disturbances (19). 

Quiz Questions

Self Quiz

Ask yourself...

  1. Considering the DSM-5 criteria for diagnosing Generalized Anxiety Disorder (GAD), how might these criteria limit or enhance our understanding of the multifaceted nature of anxiety disorders?  

 

Common Treatments 

Treatment for anxiety disorders often involves a multidimensional approach.  

Cognitive Behavioral Therapy (CBT) is one of the most effective psychotherapeutic treatments, aimed at challenging and altering thought patterns and behaviors contributing to anxiety (20).  

Medications, including Selective Serotonin Reuptake Inhibitors (SSRIs), can be used along with other treatment options such as pregabalin, tricyclic antidepressants, buspirone, and moclobemide (21).  

Lifestyle modifications such as regular exercise, improved sleep, and stress management techniques like mindfulness and meditation can improve patient outcomes (21).

Quiz Questions

Self Quiz

Ask yourself...

  1. Given the multidimensional approach to treating anxiety disorders, which includes CBT and a range of medications as well as lifestyle modifications, how should clinicians prioritize these treatments?  
  2. What factors should be considered in determining the most appropriate treatment combination for an individual patient? 

Caffeine  

Caffeine is the most consumed central nervous system stimulant (CNS) in the world; it is often found in varying amounts in beverages like coffee, tea, Guarana, workout supplements, and energy drinks, as well as in chocolate and certain medications (22).  

Caffeine is an alkaloid compound belonging to the methylxanthine class (22). From a molecular standpoint, caffeine is classified as 1,3,7-trimethylxanthine, and its primary mechanism of action is as an adenosine receptor antagonist (22). This mechanism is crucial for understanding its stimulant properties, as it leads to increased neurotransmitter release, dopamine and norepinephrine, elevating mood, focus, and overall cognitive function.  

Caffeine is absorbed within about 45 minutes of consumption, peaks in the blood plasma anywhere from 15 minutes to 2 hours and has a half-life in healthy individuals is about 5 hours (22) (23). 

Quiz Questions

Self Quiz

Ask yourself...

  1. Considering that caffeine’s primary mechanism of action is as an adenosine receptor antagonist, leading to elevated mood and focus, how might this impact individuals with existing mood or cognitive disorders?
  2. Given that caffeine is absorbed and metabolized at different rates, how may this variability influence the effects on people with different metabolic rates?

Amount of Caffeine  

The caffeine content in common beverages and foods can range from 1.5 to 6 mg of caffeine per ounce in milk chocolate, 20 mg in a cup of decaffeinated coffee, to as much as 400 mg in some energy drinks (23). A typical 8-ounce cup of brewed coffee contains approximately 80-100 mg of caffeine.  

The U.S. Food and Drug Administration (FDA) recommends a maximum daily intake of 400 mg of caffeine, roughly equivalent to four 8-ounce cups of brewed coffee (22). The lethal amount of caffeine consumed via oral methods in humans ranges from 10 to 14 grams, or 150 to 200 milligrams per kilogram of body weight (24).

Quiz Questions

Self Quiz

Ask yourself...

  1. Given the wide range of caffeine content in common foods and beverages, and the FDA’s recommendation of a maximum daily intake of 400 mg, how might this impact consumer awareness and decision-making?  
  2. Should there be more stringent labeling requirements or public health campaigns to inform people about the potential risks considering the lethal amount of caffeine? 

Effects of Caffeine 

Caffeine is known and often consumed for its ability to increase alertness, improve mood, and enhance cognitive, memory and physical performance (25). Caffeine influences the cardiovascular system with positive inotropic and chronotropic effects, and the central nervous system, with anxiogenic-like effects (25).  

Caffeine blocks adenosine A2A receptors (A2ARs) in the brain, which promotes sleep and relaxation. Excessive caffeine intake can result in unwanted effects including jitteriness, insomnia, elevated heart rate, anxiety, and digestive issues (26).

Quiz Questions

Self Quiz

Ask yourself...

  1. Considering caffeine’s dual impact on both enhancing alertness and cognitive performance while also causing negative effects like anxiety and insomnia, how should individuals and healthcare professionals balance these outcomes?  

Caffeine and Anxiety 

While caffeine’s stimulating effects can be beneficial, it can exacerbate symptoms of anxiety disorders. The heightened state of alertness from caffeine can tip over into feelings of nervousness, restlessness, and irritability (22).  

For those prone to panic attacks, the physical symptoms induced by caffeine, such as rapid heartbeat, can mimic the symptoms of an attack, leading to increased anxiety or triggering a definitive panic attack (27). Studies confirm that 5 cups of coffee can induce panic attacks in a large proportion of panic disorder (PD) patients and increase anxiety in PD patients as well as among healthy adults. However, the exact relationship between caffeine-induced anxiety and panic attacks remains uncertain (27).

Quiz Questions

Self Quiz

Ask yourself...

  1. What considerations should healthcare providers weigh when recommending dietary guidelines on caffeine consumption for patients with anxiety disorders or prone to panic attacks?

Caffeine Withdrawal 

Regular use of caffeine can lead to physical dependence, and abrupt cessation can trigger withdrawal symptoms. The intensity of symptoms differs among individuals and can include headaches, fatigue, reduced energy levels, decreased attentiveness, sleepiness, lowered sense of well-being, mood depression, trouble focusing, irritability, and a feeling of mental cloudiness (28). Withdrawal symptoms can appear within 12 to 24 hours of discontinuing caffeine intake and may persist for up to nine days (28). The symptoms can range in severity from mild to severe. 

Quiz Questions

Self Quiz

Ask yourself...

  1. Can you discuss possible withdrawal symptoms of caffeine?
  2. How should the risks of dependency and withdrawal be balanced against any perceived benefits of caffeine consumption?

Alternatives to Caffeine 

Alternatives to caffeine include herbal teas, adaptogenic herbs, physical exercise, and a balanced diet. Herbal teas, including chamomile and peppermint, offer a caffeine-free relaxation option (29). Adaptogenic herbs like Ashwagandha and Rhodiola Rosea possess stress-relieving attributes (30). Physical activity can elevate energy levels and consuming a balanced diet rich in nutrients can keep your energy levels stable (31). 

Quiz Questions

Self Quiz

Ask yourself...

  1. What factors should healthcare providers consider when recommending alternatives to caffeine, such as herbal teas or adaptogenic herbs? 

Patient Education on Caffeine and Anxiety 

Caffeine is a natural stimulant often found in coffee, tea, and energy drinks (22). Caffeine works by blocking adenosine, a neurotransmitter that makes individuals feel tired, thereby increasing alertness and energy levels (25). While moderate caffeine consumption has some benefits like improved focus and mental alertness, excessive caffeine intake can induce several side effects, including increased levels of anxiety (25).  

If your patients are prone to anxiety or panic disorders, consider strategies to limit caffeine intake. Caffeine management strategies include metered caffeine consumption to mitigate withdrawal symptoms and alleviate anxiety. Caffeine-free beverages and natural energy-boosting alternatives like herbal teas or adaptogenic herbs (29).  

For patients experiencing persistent anxiety, seeking the guidance of healthcare professionals for a comprehensive treatment approach, which may include cognitive-behavioral therapy or medication (20).  

Keeping a log of caffeine intake and associated symptoms to identify patterns and customize management strategies can be helpful.

 

 

Quiz Questions

Self Quiz

Ask yourself...

  1. How can healthcare professionals guide patients in balancing the potential benefits of caffeine for mental alertness with the risks of exacerbating anxiety disorders?
  2. What role do individual patient profiles play in determining the most appropriate caffeine management strategy?

Conclusion

Caffeine can be a powerful tool for enhancing focus and alertness, but it is not without its drawbacks (25) (26). For those predisposed to anxiety disorders, caffeine can exacerbate existing anxiety disorders and trigger new ones (27). If healthcare providers suspect that caffeine is contributing to a patient’s anxiety symptoms, consider recommending the gradual reduction of caffeine intake.

For healthcare providers and patients, awareness of caffeine’s effects and moderation are key in finding a balanced approach that allows benefits from its upsides while mitigating caffeine’s downsides.

 

References + Disclaimer

  1. Anxiety disorders. (2023). National Institute of Mental Health (NIMH). https://www.nimh.nih.gov/health/topics/anxiety-disorders 
  2. Yum, L. D. (2023). Facts and statistics about anxiety disorders. CHC Resource Library | CHC | Services for Mental Health and Learning Differences for Young Children, Teens, and Young Adults | Palo Alto, San Jose, Ravenswood. https://www.chconline.org/resourcelibrary/facts-and-statistics-about-anxiety-disorders/ 
  3. World Health Organization: WHO. (2023). Anxiety disorders. www.who.int. https://www.who.int/news-room/fact-sheets/detail/anxiety-disorders 
  4. Bandelow, B., & Michaelis, S. (2015). Epidemiology of anxiety disorders in the 21st century. Dialogues in Clinical Neuroscience, 17(3), 327–335. https://doi.org/10.31887/dcns.2015.17.3/bbandelow 
  5. McLean, C. P., Asnaani, A., Litz, B. T., & Hofmann, S. (2011). Gender differences in anxiety disorders: Prevalence, course of illness, comorbidity, and burden of illness. Journal of Psychiatric Research, 45(8), 1027–1035. https://doi.org/10.1016/j.jpsychires.2011.03.006 
  6. Kundaković, M., & Rocks, D. (2022). Sex hormone fluctuation and increased female risk for depression and anxiety disorders: From clinical evidence to molecular mechanisms. Frontiers in Neuroendocrinology, 66, 101010. https://doi.org/10.1016/j.yfrne.2022.101010 
  7. Chatmon, B. N. (2020). Males and mental health stigma. American Journal of Men’s Health, 14(4), 155798832094932. https://doi.org/10.1177/1557988320949322 
  8. Beesdo, K., Knappe, S., & Pine, D. S. (2009). Anxiety and Anxiety disorders in children and Adolescents: Developmental issues and implications for DSM-V. Psychiatric Clinics of North America, 32(3), 483–524. https://doi.org/10.1016/j.psc.2009.06.002 
  9. Van Ameringen, M., Mancini, C., & Farvolden, P. (2003). The impact of anxiety disorders on educational achievement. Journal of Anxiety Disorders, 17(5), 561–571. https://doi.org/10.1016/s0887-6185(02)00228-1 
  10. British Psychological Society (UK). (2013). SOCIAL ANXIETY DISORDER. Social Anxiety Disorder – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK327674/ 
  11. Mental Health and Substance Use Co-Occurring Disorders. (2023). SAMHSA. https://www.samhsa.gov/mental-health/mental-health-substance-use-co-occurring-disorders 
  12. Statistics. (2023.). National Institute of Mental Health (NIMH). https://www.nimh.nih.gov/health/statistics 
  13. Muntañer, C. (2004). Socioeconomic position and major mental disorders. Epidemiologic Reviews, 26(1), 53–62. https://doi.org/10.1093/epirev/mxh001 
  14. Schneiderman, N., Ironson, G., & Siegel, S. D. (2005). Stress and health: psychological, behavioral, and biological determinants. Annual Review of Clinical Psychology, 1(1), 607–628. https://doi.org/10.1146/annurev.clinpsy.1.102803.144141 
  15. Norrholm, S. D., & Ressler, K. J. (2009). Genetics of anxiety and trauma-related disorders. Neuroscience, 164(1), 272–287. https://doi.org/10.1016/j.neuroscience.2009.06.036 
  16. Gottschalk, M. G., & Domschke, K. (2017). Genetics of generalized anxiety disorder and related traits. Dialogues in Clinical Neuroscience, 19(2), 159–168. https://doi.org/10.31887/dcns.2017.19.2/kdomschke 
  17. Martin, E., Ressler, K. J., Binder, E. B., & Nemeroff, C. B. (2009). The Neurobiology of Anxiety Disorders: brain imaging, genetics, and Psychoneuroendocrinology. Psychiatric Clinics of North America, 32(3), 549–575. https://doi.org/10.1016/j.psc.2009.05.004 
  18. Ressler, K. J. (2010). Amygdala activity, fear, and anxiety: Modulation by stress. Biological Psychiatry, 67(12), 1117–1119. https://doi.org/10.1016/j.biopsych.2010.04.027 
  19. Substance Abuse and Mental Health Services Administration (US). (2023). Table 3.15, DSM-IV to DSM-5 Generalized Anxiety Disorder Comparison – Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK519704/table/ch3.t15/ 
  20. Curtiss, J. E. (2021). Cognitive-Behavioral Treatments for Anxiety and Stress-Related Disorders. FOCUS. https://focus.psychiatryonline.org/doi/10.1176/appi.focus.20200045 
  21. Bandelow, B., Michaelis, S., & Wedekind, D. (2017). Treatment of anxiety disorders. Dialogues in Clinical Neuroscience, 19(2), 93–107. https://doi.org/10.31887/dcns.2017.19.2/bbandelow 
  22. Evans, J. (2023, June 8). Caffeine. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK519490/ 
  23. Caffeine. (2023, February 2). The Nutrition Source. https://www.hsph.harvard.edu/nutritionsource/caffeine/ 
  24. National Academies Press (US). (2001). Pharmacology of caffeine. Caffeine for the Sustainment of Mental Task Performance – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK223808/ 
  25. Cappelletti, S., Piacentino, D., Sani, G., & Aromatario, M. (2015). Caffeine: cognitive and physical performance enhancer or psychoactive drug? Current Neuropharmacology, 13(1), 71–88. https://doi.org/10.2174/1570159×13666141210215655 
  26. Lazarus, M., Shen, H., Chérasse, Y., Qu, W. M., Huang, Z., Bass, C. E., Winsky‐Sommerer, R., Semba, K., Fredholm, B. B., Boison, D., Hayaishi, O., Urade, Y., & Chen, J. (2011). Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. The Journal of Neuroscience, 31(27), 10067–10075. https://doi.org/10.1523/jneurosci.6730-10.2011 
  27. Klevebrant, L., & Frick, A. (2022). Effects of caffeine on anxiety and panic attacks in patients with panic disorder: A systematic review and meta-analysis. General Hospital Psychiatry, 74, 22–31. https://doi.org/10.1016/j.genhosppsych.2021.11.005 
  28. Sajadi-Ernazarova, K. R. (2023, August 8). Caffeine withdrawal. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK430790/ 
  29. Khan, N., & Mukhtar, H. (2013). Tea and Health: Studies in Humans. Current Pharmaceutical Design, 19(34), 6141–6147. https://doi.org/10.2174/1381612811319340008 
  30. Panossian, A., & Wikman, G. (2010). Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress—Protective Activity. Pharmaceuticals, 3(1), 188–224. https://doi.org/10.3390/ph3010188 
  31. Benefits of physical activity. (2023, August 1). Centers for Disease Control and Prevention. https://www.cdc.gov/physicalactivity/basics/pa-health/index.htm 

 

Disclaimer:

Use of Course Content. The courses provided by NCC are based on industry knowledge and input from professional nurses, experts, practitioners, and other individuals and institutions. The information presented in this course is intended solely for the use of healthcare professionals taking this course, for credit, from NCC. The information is designed to assist healthcare professionals, including nurses, in addressing issues associated with healthcare. The information provided in this course is general in nature and is not designed to address any specific situation. This publication in no way absolves facilities of their responsibility for the appropriate orientation of healthcare professionals. Hospitals or other organizations using this publication as a part of their own orientation processes should review the contents of this publication to ensure accuracy and compliance before using this publication. Knowledge, procedures or insight gained from the Student in the course of taking classes provided by NCC may be used at the Student’s discretion during their course of work or otherwise in a professional capacity. The Student understands and agrees that NCC shall not be held liable for any acts, errors, advice or omissions provided by the Student based on knowledge or advice acquired by NCC. The Student is solely responsible for his/her own actions, even if information and/or education was acquired from a NCC course pertaining to that action or actions. By clicking “complete” you are agreeing to these terms of use.

 

Complete Survey

Give us your thoughts and feedback

Click Complete

To receive your certificate

Want to earn credit for this course? Sign up (new users) or Log in (existing users) to complete this course for credit and receive your certificate instantly.